Skip to main content
SpringerLink
Log in

Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways

  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Inflammation/Autoimune Diseases, Hoffmann-LaRoche Inc., 340 Kingsland Street, Nutley, NJ 07110, USA, Fax +1 201 235 3805, e-mail: Louis_M.Renzetti@Roche.com, , , , , , US

    L. M. Renzetti & P. R. Gater

Authors
  1. L. M. Renzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. R. Gater
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renzetti, L., Gater, P. Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways. Inflamm. res. 46 (Suppl 2), 143–144 (1997). https://doi.org/10.1007/s000110050146

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000110050146

Keywords

Search

Navigation